News & Trends - MedTech & Diagnostics
Medtronic secures 2019 MedTech Kerrin Rennie Award
The winner of the 14th Kerrin Rennie Award was announced at the annual MedTech Awards Dinner, with the award going to Medtronic for the MiniMed 670G System.
The MiniMed 670G is an insulin pump system which automatically self-adjusts to deliver people living with type 1 diabetes (T1D) precise amounts of insulin when they need it – regardless of whether they are asleep or on the go. The only technology of its type approved in Australia, the insulin pump system intuitively administers insulin as needed and also withholds insulin release when a drop in sugar levels is detected – a long-awaited breakthrough in the Australian diabetes community in their quest to better manage the chronic disease. The system is designed to learn an individual’s insulin needs by measuring the glucose level of people living with T1D every five minutes and to take action to minimise both high and low glucose levels. As a result, the technology requires minimal input providing peace of mind for the users.
The other Awards recipients included:
- George Faithfull, Stryker VP of Government & Regulatory Affairs – Outstanding Achievement in MedTech
- Steven Flynn, Baxter Healthcare ANZ MD – Women in MedTech Champion (individual)
- Baxter Healthcare – Women in MedTech Champion (company)
Ian Burgess, Chief Executive Officer of the Medical Technology Association of Australia (MTAA) said:
“The MTAA Annual Industry Awards are an opportunity to recognise our members and individuals who have contributed to improving patient outcomes through MedTech.
“This year we received a record number of entries, a clear indication of the hard work and innovation that goes on every day in the MedTech industry.
“It’s inspiring to be part of the medical technology industry that every day is focused on improving the health and wellbeing of patients.”
You may also like Keeping premiums low: Towards a sustainable private healthcare system – MTAA welcomes AlphaBeta report
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More